Timber Pharmaceuticals changes name to Trex Wind-down after asset sale to LEO Pharma in Chapter 11

TREX WIND-DOWN, INC.

Name changed to Trex Wind-down, Inc. effective Jan 23, 2024.
Closed sale of substantially all assets to LEO Pharma A/S on Jan 22, 2024 under stalking horse APA.
Company and subsidiaries remain in Chapter 11 bankruptcy (Case No. 23-11878, D. Del.).
Filed monthly operating reports for Dec 2023 with Bankruptcy Court for the debtors.
Company warns trading in its securities during Chapter 11 is highly speculative.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

TREX WIND-DOWN, INC.: Amended certificate of incorporation to change corporate name from Timber Pharmaceuticals, Inc. to Trex Wind-down, Inc (effective 2024-01-23).

Change: charter amendment
Effective: 2024-01-23

Exact text from the filing

On January 23, 2024, Trex Wind-down, Inc. (f/k/a Timber Pharmaceuticals, Inc.) (the “Company”) filed with the Secretary of State of the State of Delaware a certificate of amendment to the Company’s certificate of incorporation, as amended (the “Name Change Amendment”), in connection with the previously announced closing of the sale of substantially all of the assets of the Company and its subsidiaries on January 22, 2024 pursuant to the “stalking horse” asset purchase agreement by and among the Debtors (as defined herein), LEO Pharma A/S and LEO Spiny Merger Sub, Inc. The Name Change Amendment did not amend the certificate of incorporation except to change the corporate name from “Timber Pharmaceuticals, Inc.” to “Trex Wind-down, Inc.”, effective January 23, 2024.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001493152-24-003838

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.